1. Zhang, Ting-Ting, Lei, Qing-Qing, He, Jie, Huang, Hui, Zhou, Jia-Guo. 2023. Bestrophin3 Deficiency in Vascular Smooth Muscle Cells Activates MEKK2/3-MAPK Signaling to Trigger Spontaneous Aortic Dissection. In Circulation, 148, 589-606. doi:10.1161/CIRCULATIONAHA.122.063029. https://pubmed.ncbi.nlm.nih.gov/37203562/
2. Tan, W Keith, Maroni, Roberta, Offman, Judith, Sasieni, Peter D, Fitzgerald, Rebecca C. 2024. Targeted Screening for Barrett's Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial. In Gastroenterology, 167, 798-800.e4. doi:10.1053/j.gastro.2024.04.030. https://pubmed.ncbi.nlm.nih.gov/38718951/
3. Maroni, Roberta, Barnes, Jessica, Offman, Judith, Rubin, Greg, Walter, Fiona M. 2022. Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial. In BMJ open, 12, e054258. doi:10.1136/bmjopen-2021-054258. https://pubmed.ncbi.nlm.nih.gov/35393308/
4. Golubinskaya, V, Elvin, J, Ebefors, K, Nyström, J, Nilsson, H. 2015. Bestrophin-3 is differently expressed in normal and injured mouse glomerular podocytes. In Acta physiologica (Oxford, England), 214, 481-96. doi:10.1111/apha.12516. https://pubmed.ncbi.nlm.nih.gov/25912364/
5. Ghimire, Bhagabati, Landy, Rebecca, Maroni, Roberta, Waller, Jo, Offman, Judith. 2023. Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial. In BMC gastroenterology, 23, 7. doi:10.1186/s12876-022-02630-1. https://pubmed.ncbi.nlm.nih.gov/36627580/